Physician profile
Michiel Noe
NPI 1306845417
$50,859.78
in general payments reported to CMS, 2019-2025
17 companies · $3,048 in 2025
The $3,048 reported for 2025 was more than what 96% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,268 · 2020: $2,119 · 2021: $354 · 2022: $12K · 2023: $20K · 2024: $11K · 2025: $3,048.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $33K · Food and Beverage: $357.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $33,403.56 |
| Food and Beverage | $357.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $45,849.95 | 2021-2025 | Nexplanon, Jada System |
| Merck Sharp & Dohme LLC | $3,996.87 | 2019-2021 | |
| Abbvie INC. | $439.42 | 2019-2022 | |
| Lupin INC. | $186.93 | 2019-2020 | |
| Avion Pharmaceuticals | $65.55 | 2021-2022 | |
| Hologic Sales and Service, LLC | $55.08 | 2021-2024 | Aptima |
| Coopersurgical, INC. | $44.57 | 2020-2023 | Paragard T 380a |
| Therapeuticsmd, INC. | $39.66 | 2020-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $31.86 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $29.82 | 2020-2022 | |
| Duchesnay USA Incorporated | $19.28 | 2019 | |
| Agile Therapeutics, INC. | $18.53 | 2022 | |
| Mayne Pharma Commercial LLC | $18.23 | 2022 | |
| Allergan, INC. | $18.16 | 2019 | |
| Octapharma USA, INC. | $16.86 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $14.51 | 2021 | |
| Mission Pharmacal Company | $14.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michiel Noe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.